Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma

Angioimmunoblastic T-cell lymphoma (AITL) can be complicated by Epstein-Barr virus (EBV)-positive B-cell lymphoma. B-cell lymphoma may develop simultaneously at the time of AITL diagnosis or after treatment for AITL. EBV-associated B-cell lymphoma can occur in nodal and extranodal sites. We report a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Akiko Hashimoto, Satsuki Asai, Yasuhiro Tanaka, Isaku Shinzato
Formato: article
Lenguaje:EN
Publicado: SMC MEDIA SRL 2021
Materias:
R
Acceso en línea:https://doaj.org/article/ce774f55475b42b7b6d8a13669d7e886
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ce774f55475b42b7b6d8a13669d7e886
record_format dspace
spelling oai:doaj.org-article:ce774f55475b42b7b6d8a13669d7e8862021-11-09T11:21:26ZEpstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma2284-259410.12890/2021_002533https://doaj.org/article/ce774f55475b42b7b6d8a13669d7e8862021-10-01T00:00:00Zhttps://www.ejcrim.com/index.php/EJCRIM/article/view/2533https://doaj.org/toc/2284-2594Angioimmunoblastic T-cell lymphoma (AITL) can be complicated by Epstein-Barr virus (EBV)-positive B-cell lymphoma. B-cell lymphoma may develop simultaneously at the time of AITL diagnosis or after treatment for AITL. EBV-associated B-cell lymphoma can occur in nodal and extranodal sites. We report a case of EBV-positive diffuse large B-cell lymphoma (DLBCL) of the left adrenal gland that developed after treatment for AITL. The patient presented with systemic lymphadenopathy and biopsy of one lymph node showed AITL. A complete response (CR) was achieved after initial chemotherapy for AITL, but 9 months later the left adrenal gland was enlarged. The diagnosis of EBV-positive DLBCL was made based on the histopathological findings of the left adrenal gland biopsy. Thus, EBV-positive DLBCL developed after AITL CR was achieved. Multi-drug chemotherapy combined with rituximab was administered for adrenal DLBCL, but only a partial response was achieved. We confirmed that EBV-positive B-cell lymphoma developed after treatment for AITL. An adrenal primary is rare, and this is only the second case of EBV-positive B-cell lymphoma to be reported after treatment for AITL. Clinicians should keep in mind that when nodal and extranodal lesions are seen after AITL treatment, another biopsy should be performed for the accurate determination of whether these lesions indicate AITL relapse or new-onset EBV-positive B-cell lymphoma.Akiko HashimotoSatsuki AsaiYasuhiro TanakaIsaku ShinzatoSMC MEDIA SRLarticleadrenal massdiffuse large b-cell lymphomaepstein-barr virusangioimmunoblastic t-cell lymphomaMedicineRENEuropean Journal of Case Reports in Internal Medicine (2021)
institution DOAJ
collection DOAJ
language EN
topic adrenal mass
diffuse large b-cell lymphoma
epstein-barr virus
angioimmunoblastic t-cell lymphoma
Medicine
R
spellingShingle adrenal mass
diffuse large b-cell lymphoma
epstein-barr virus
angioimmunoblastic t-cell lymphoma
Medicine
R
Akiko Hashimoto
Satsuki Asai
Yasuhiro Tanaka
Isaku Shinzato
Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
description Angioimmunoblastic T-cell lymphoma (AITL) can be complicated by Epstein-Barr virus (EBV)-positive B-cell lymphoma. B-cell lymphoma may develop simultaneously at the time of AITL diagnosis or after treatment for AITL. EBV-associated B-cell lymphoma can occur in nodal and extranodal sites. We report a case of EBV-positive diffuse large B-cell lymphoma (DLBCL) of the left adrenal gland that developed after treatment for AITL. The patient presented with systemic lymphadenopathy and biopsy of one lymph node showed AITL. A complete response (CR) was achieved after initial chemotherapy for AITL, but 9 months later the left adrenal gland was enlarged. The diagnosis of EBV-positive DLBCL was made based on the histopathological findings of the left adrenal gland biopsy. Thus, EBV-positive DLBCL developed after AITL CR was achieved. Multi-drug chemotherapy combined with rituximab was administered for adrenal DLBCL, but only a partial response was achieved. We confirmed that EBV-positive B-cell lymphoma developed after treatment for AITL. An adrenal primary is rare, and this is only the second case of EBV-positive B-cell lymphoma to be reported after treatment for AITL. Clinicians should keep in mind that when nodal and extranodal lesions are seen after AITL treatment, another biopsy should be performed for the accurate determination of whether these lesions indicate AITL relapse or new-onset EBV-positive B-cell lymphoma.
format article
author Akiko Hashimoto
Satsuki Asai
Yasuhiro Tanaka
Isaku Shinzato
author_facet Akiko Hashimoto
Satsuki Asai
Yasuhiro Tanaka
Isaku Shinzato
author_sort Akiko Hashimoto
title Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
title_short Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
title_full Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
title_fullStr Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
title_full_unstemmed Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
title_sort epstein-barr virus-positive adrenal diffuse large b-cell lymphoma after treatment for angioimmunoblastic t-cell lymphoma
publisher SMC MEDIA SRL
publishDate 2021
url https://doaj.org/article/ce774f55475b42b7b6d8a13669d7e886
work_keys_str_mv AT akikohashimoto epsteinbarrviruspositiveadrenaldiffuselargebcelllymphomaaftertreatmentforangioimmunoblastictcelllymphoma
AT satsukiasai epsteinbarrviruspositiveadrenaldiffuselargebcelllymphomaaftertreatmentforangioimmunoblastictcelllymphoma
AT yasuhirotanaka epsteinbarrviruspositiveadrenaldiffuselargebcelllymphomaaftertreatmentforangioimmunoblastictcelllymphoma
AT isakushinzato epsteinbarrviruspositiveadrenaldiffuselargebcelllymphomaaftertreatmentforangioimmunoblastictcelllymphoma
_version_ 1718441149952163840